Prostate Cancer Clinical Trials in Aurora, Colorado

7 studies are recruiting for prostate cancer in Aurora, Colorado right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

    Researchers are looking for new ways to treat metastatic castration-resistant prostate cancer (mCRPC). Researchers have designed a study medicine called ifinatamab deruxtecan (also called I-DXd or MK-2400) to treat mCRPC. The goal of this study is to learn if people who receive I-DXd live longer ov…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Rocky Mountain Regional Veterans Affairs Medical Center ( Site 0053), Aurora, Colorado
    Locations
    298 in total
    Run by
    Merck Sharp & Dohme LLC
  2. Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

    The overall aim of the trial is to evaluate the safety, tolerability, and pharmacokinetics (PK) of AMG 509 (monotherapy and in combination with abiraterone acetate and enzalutamide) and to evaluate preliminary efficacy. As of Protocol Amendment 10 (09 July 2025), only Parts 4A expansion, 6, and 7 a…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Rocky Mountain Cancer Centers, Aurora, Colorado
    Locations
    57 in total
    Run by
    Amgen
  3. A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC

    This is a dose-finding study to assess the safety and preliminary antitumor activity of Pocenbrodib alone or with darolutamide in patients with metastatic castration-resistant prostate cancer (mCRPC)

    Stage
    Phase 1
    Ages
    18 and older
    Site
    University of Colorado Health, Aurora, Colorado
    Locations
    19 in total
    Run by
    Pathos AI, Inc.
  4. FOG-001 in Locally Advanced or Metastatic Solid Tumors

    The goal of this clinical trial is to determine if FOG-001 is safe and effective in participants with locally advanced or metastatic solid tumors or in participants with familial adenomatous polyposis (FAP).

    Stage
    Phase 1
    Ages
    18 and older
    Site
    University of Colorado, Aurora, Colorado
    Locations
    33 in total
    Run by
    Parabilis Medicines, Inc.
  5. Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

    The purpose of this post-marketing study is to further characterize the long-term outcome of known or potential risks of lutetium (177Lu) vipivotide tetraxetan also known as [177Lu]Lu-PSMA-617 or 177Lu-PSMA-617 and hereinafter referred to as AAA617. The study also seeks to further characterize (as …

    Stage
    Phase 4
    Ages
    18 to 100
    Site
    University of Colorado, Aurora, Colorado
    Locations
    54 in total
    Run by
    Novartis Pharmaceuticals
  6. Pragmatic Trial of Metformin for Glucose Intolerance or Increased BMI in Prostate Cancer Patients

    Metformin is used widely in the treatment of type 2 diabetes. It has off-label indications for use in the prevention of diabetes and in hyperinsulinar obesity. In medical practices, the implementation of metformin for these off-label indications is variable, often at the level of the provider. Mult…

    Stage
    EARLY_Phase 1
    Ages
    18 and older
    Site
    Colorado Research Center, Aurora, Colorado
    Locations
    4 in total
    Run by
    University of Colorado, Denver
  7. Telehealth Exercise Program Evaluating Fatigue and Physical Function in Rural Cancer Survivors

    This study investigates the efficacy of a telehealth exercise program designed specifically for rural cancer survivors with cancer-related fatigue (CRF). Small dried blood samples and measures of physical function will be collected throughout the program. The main questions it aims to answer are: *…

    Stage
    Phase 2
    Ages
    18 to 89
    Site
    University of Colorado Anschutz Medical Campus, Aurora, Colorado
    Locations
    2 in total
    Run by
    University of Colorado, Denver

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.